| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Valtteri Kaasinen, Sargo Aalto, Kjell Någren, Juha O Rinn. Expectation of caffeine induces dopaminergic responses in humans. The European journal of neuroscience. vol 19. issue 8. 2004-06-18. PMID:15090062. |
the present study aimed to investigate neurotransmitter function in psychostimulant expectation, with the focus on dopaminergic effects of placebo caffeine in healthy human subjects. |
2004-06-18 |
2023-08-12 |
human |
| Grazyna Skuz. Potential antidepressant activity of sigma ligands. Polish journal of pharmacology. vol 55. issue 6. 2004-06-15. PMID:14730086. |
moreover, sigma ligands are able to modulate the activity of the central neurotransmitter systems, including noradrenergic, serotonergic, dopaminergic and glutamatergic (nmda) ones, which are seemingly important for the mechanism of action of known ads. |
2004-06-15 |
2023-08-12 |
Not clear |
| Rose-Marie Marié, Gilles-Louis Defe. Working memory and dopamine: clinical and experimental clues. Current opinion in neurology. vol 16 Suppl 2. 2004-06-03. PMID:15129848. |
the involvement of monoaminergic neurotransmitter systems, and in particular of the dopaminergic system, in these complex cognitive functions has been suggested by numerous studies, both in humans and in non-human primates. |
2004-06-03 |
2023-08-12 |
Not clear |
| Wei Zhang, Tongguang Wang, Liya Qin, Hui-Ming Gao, Belinda Wilson, Syed F Ali, Wanqin Zhang, Jau-Shyong Hong, Bin Li. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 18. issue 3. 2004-06-01. PMID:14734632. |
parkinson's disease (pd) is a neurodegenerative movement disorder characterized by a progressive loss of dopaminergic neurons in the substantia nigra and depletion of the neurotransmitter dopamine in the striatum. |
2004-06-01 |
2023-08-12 |
mouse |
| Monsheel S K Sodhi, Elaine Sanders-Bus. Serotonin and brain development. International review of neurobiology. vol 59. 2004-05-10. PMID:15006487. |
the serotonergic system interacts with brain-derived neurotrophic factor (bdnf), s100beta, and other chemical messengers, in addition to ts cross talk with the gabaergic, glutamatergic, and dopaminergic neurotransmitter systems. |
2004-05-10 |
2023-08-12 |
Not clear |
| Tiziano Barberi, Peter Klivenyi, Noel Y Calingasan, Hyojin Lee, Hibiki Kawamata, Kathleen Loonam, Anselme L Perrier, Juan Bruses, Maria E Rubio, Norbert Topf, Viviane Tabar, Neil L Harrison, M Flint Beal, Malcolm A S Moore, Lorenz Stude. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nature biotechnology. vol 21. issue 10. 2004-04-28. PMID:14502203. |
neuronal function of es cell-derived dopaminergic neurons was shown in vitro by electron microscopy, measurement of neurotransmitter release and intracellular recording. |
2004-04-28 |
2023-08-12 |
mouse |
| A C Z Baso, F C Goulart, E Teodorov, L F Felício, M M Bernard. Effects of maternal exposure to picrotoxin during lactation on physical and reflex development, square crossing and sexual behavior of rat offspring. Pharmacology, biochemistry, and behavior. vol 75. issue 4. 2004-04-13. PMID:12957213. |
three hypotheses were proposed to explain the mechanisms underlying this effect: (1) the development of subsensitivity of gabaergic receptors, (2) an interference with early receptor development or (3) with neurotransmitter balance, mainly involving the dopaminergic system. |
2004-04-13 |
2023-08-12 |
rat |
| Amani E Khalif. Zuclopenthixol facilitates memory retrieval in rats: possible involvement of noradrenergic and serotonergic mechanisms. Pharmacology, biochemistry, and behavior. vol 75. issue 4. 2004-04-13. PMID:12957216. |
the neurocognitive profile of zuclopenthixol, a thioxanthene dopaminergic antagonist and a conventional neuroleptic agent, has yet to be investigated despite the effect of the drug on a variety of neurotransmitter systems involved in mediation of learning and memory processes. |
2004-04-13 |
2023-08-12 |
rat |
| Klaus L Leender. Significance of non-presynaptic SPECT tracer methods in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 18 Suppl 7. 2004-03-29. PMID:14531045. |
tropane-related tracers for spect and pet scanning have shown their value in assessing the in vivo striatal presynaptic status of the dopaminergic neurotransmitter system in man. |
2004-03-29 |
2023-08-12 |
Not clear |
| Gesine Paul, Wassilios Meissner, Susanne Rein, Daniel Harnack, Christine Winter, Kai Hosmann, Rudolf Morgenstern, Andreas Kupsc. Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Experimental neurology. vol 185. issue 2. 2004-03-02. PMID:14736508. |
we conclude that subthalamic nucleus ablation exerts neuroprotective properties on the dopaminergic nigrostriatal pathway against 6-hydroxydopamine toxicity in terms of rescuing the neurotransmitter phenotype in the remaining neurons rather than enhancing the total number of nigral cells. |
2004-03-02 |
2023-08-12 |
rat |
| Uriel Heresco-Lev. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality. Progress in neuro-psychopharmacology & biological psychiatry. vol 27. issue 7. 2004-02-24. PMID:14642971. |
the neurotransmission mediated by the excitatory amino acids (eaa) glutamate (glu) and aspartate is of interest to the pharmacotherapy of psychosis due to its role in neurodevelopment and neurotoxicity, its complex interactions with dopaminergic and other neurotransmitter systems and its pivotal importance in recent models of schizophrenia. |
2004-02-24 |
2023-08-12 |
Not clear |
| Torgny H Svensso. Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality. Progress in neuro-psychopharmacology & biological psychiatry. vol 27. issue 7. 2004-02-24. PMID:14642973. |
clozapine, as well as several other atypicals, displays significant affinities also for several other neurotransmitter receptors, including other dopaminergic receptors, alpha-adrenergic receptors and different serotonergic and cholinergic receptors, which in several ways may contribute to the clinical effectiveness of the drugs. |
2004-02-24 |
2023-08-12 |
Not clear |
| M Keitz, C Martin-Soelch, K L Leender. Reward processing in the brain: a prerequisite for movement preparation? Neural plasticity. vol 10. issue 1-2. 2004-02-18. PMID:14640313. |
the cerebral dopaminergic neurotransmitter circuitry does play an important role in the organization of both the motor and motivational system. |
2004-02-18 |
2023-08-12 |
human |
| Sk Jamaluddin, Mrinal K Podda. Brain regional gamma-aminobutyric acid (GABA) and locomotor activity: effect of long-term aldrin exposure. Polish journal of pharmacology. vol 55. issue 3. 2004-02-06. PMID:14506316. |
moreover, the studies of the interaction between neurotransmitters (using agonist(s) and antagonist(s) of the respective neurotransmitter receptors) showed that long-term administration of aldrin restored the la to control value by upregulation of central gabaergic activity through the interaction with dopaminergic and cholinergic systems. |
2004-02-06 |
2023-08-12 |
rat |
| Masahisa Yamada, Anthony S Basile, Irina Fedorova, Weilie Zhang, Alokesh Duttaroy, Yinghong Cui, Kathryn G Lamping, Frank M Faraci, Chu Xia Deng, Jürgen Wes. Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology. Life sciences. vol 74. issue 2-3. 2004-01-05. PMID:14607263. |
in addition, in vitro neurotransmitter release experiments indicated that m(5) receptors located on dopaminergic nerve terminals play a role in facilitating muscarinic agonist-induced dopamine release in the striatum, consistent with the observation that the dopaminergic neurons innervating the striatum almost exclusively express the m(5) receptor subtype. |
2004-01-05 |
2023-08-12 |
mouse |
| Simone M Smits, Tiia Ponnio, Orla M Conneely, J Peter H Burbach, Marten P Smid. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. The European journal of neuroscience. vol 18. issue 7. 2003-12-19. PMID:14622207. |
involvement of nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. |
2003-12-19 |
2023-08-12 |
mouse |
| Jenice D'Costa, Judith Harvey-White, Pankaj Qasba, Advait Limaye, Christine R Kaneski, Alberta Davis-Warren, Roscoe O Brady, Krys S Bankiewicz, Eugene O Major, Suresh K Ary. HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro. Journal of medical virology. vol 71. issue 2. 2003-11-25. PMID:12938190. |
parkinson's disease is a focal degeneration of dopaminergic neurons in the brain with progressive loss of ability to produce the neurotransmitter dopamine. |
2003-11-25 |
2023-08-12 |
Not clear |
| M Gruss, J Bock, K Brau. Haloperidol impairs auditory filial imprinting and modulates monoaminergic neurotransmission in an imprinting-relevant forebrain area of the domestic chick. Journal of neurochemistry. vol 87. issue 3. 2003-11-24. PMID:14535951. |
these results indicate that the modulation of dopaminergic function and its interaction with other neurotransmitter systems in a higher associative forebrain region of the juvenile avian brain displays similar neurochemical characteristics as the adult mammalian prefrontal cortex. |
2003-11-24 |
2023-08-12 |
chicken |
| Francesco Benedetti, Alessandro Serretti, Cristina Colombo, Roberta Lilli, Cristina Lorenzi, Enrico Smerald. Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression. Psychiatry research. vol 118. issue 3. 2003-11-12. PMID:12834818. |
total sleep deprivation (tsd) is an effective treatment for mood disorders that is thought to act through an enhancement in several neurotransmitter pathways including dopaminergic transmission. |
2003-11-12 |
2023-08-12 |
Not clear |
| Mona Boules, Paul Fredrickson, Elliott Richelso. Current topics: brain penetrating neurotensin analog. Life sciences. vol 73. issue 22. 2003-10-23. PMID:14511764. |
it is closely associated with dopaminergic and other neurotransmitter systems, and evidence supports a role for nt in various neuropsychiatric disorders. |
2003-10-23 |
2023-08-12 |
Not clear |